Valiant Laboratories sees strong debut; lists over 16% premium on bourses; Should you hold or book profit-

Valiant Laboratories shares listed at 15.82% premium over IPO price on bourses. The share debuted at Rs 162.15 on the NSE and at Rs 161 on the BSE, as compared to the issue price of Rs 140.  The investors have made a profit of Rs 22.15 per share as the scrip gave nearly 16% return to investors on the listing.

Also Read

Bandhan Bank: Jefferies recommends Buy, price target at Rs 280 with 10% upside

Should you hold or book profit ?

The IPO was subscribed 29.76 times, indicating a positive response from investors. “Overall, the listing of Valiant Laboratories was positive, with the company receiving a good response from investors. However, investors should carefully consider related risks as well, like the company’s single-product focus, dependence on a limited number of suppliers and customers, and the competitive industry. Thus, investors are advised to book profits and exit their positions, but those who want to hold for the long t…